lomustine has been researched along with cephalexin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aubry, OA; Christopherson, PW; Kennis, RA; Mastrorilli, C; Moore, PF; Newton, JC; Smith, AN; Spangler, EA; Weismann, JL | 1 |
1 review(s) available for lomustine and cephalexin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for lomustine and cephalexin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multifocal cutaneous histiocytic sarcoma in a young dog and review of histiocytic cell immunophenotyping.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Antineoplastic Agents; Biopsy, Fine-Needle; Cephalexin; Dendritic Cells; Dog Diseases; Dogs; Doxorubicin; Fatal Outcome; Histiocytes; Histiocytic Sarcoma; Histiocytosis; Immunophenotyping; Lomustine; Male; Prednisone; Skin; Skin Neoplasms | 2012 |